Prescription drug · NDA
Nereus (tradipitant) NDC 43068-585
Tradipitant 85 mg/1 · Capsule · Oral · Vanda Pharmaceuticals Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 43068-585-01 | 43068058501 | 60 CARTON in 1 BOTTLE (43068-585-01) / 1 CAPSULE in 1 CARTONMarketed from Mar 31, 2026 | |
| 43068-585-02 | 43068058502 | 36 CARTON in 1 BOTTLE (43068-585-02) / 1 CAPSULE in 1 CARTONMarketed from Mar 31, 2026 | |
| 43068-585-03 | 43068058503 | 2 BLISTER PACK in 1 KIT (43068-585-03) / 1 CAPSULE in 1 BLISTER PACKMarketed from Mar 31, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Nereus
- Generic name (nonproprietary)
- tradipitant
- Active ingredients
- Tradipitant — 85 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- Vanda Pharmaceuticals Inc.
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 220152
- Marketing start
- Listing expires
- Identifiers
- Product ID 43068-585_d6537ef2-ed58-4c3a-82ae-e41273cd4c7bSPL ID d6537ef2-ed58-4c3a-82ae-e41273cd4c7bSPL set ID 1a021ebd-16ac-4354-b4b2-1c3950c091e5RxCUI 2739511, 2739517UNII NY0COC51FIUPC 0343068304025, 0343068585035, 0343068585028
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N443068058501followed by a unit qualifier and the quantityPackage 43068-0585-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
NEREUS is indicated for the prevention of vomiting induced by motion in adults. NEREUS is a substance P/neurokinin 1 (NK1) receptor antagonist indicated for the prevention of vomiting induced by motion in adults. ( 1 )
Excerpt only. Read the full label for complete information.